China conditionally approves four self-developed COVID-19 vaccines: official
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Green Ribbon Action event promotes better digestive system healthcare
- Former vice head of Chinese Football Association stands trial for bribery
- Indonesia's president-elect to visit China
- Luxembourg returns China's favor with exhibit in Henan
- Foreigners make nearly 3 million inbound, outbound trips to China in Jan-Feb
- Xi shares views and insights into China-US ties